Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7718695

Concept As at
2018-09-30
2018-07-01 to
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-07-01 to
2017-09-30
As at
2017-09-30
2017-04-01 to
2017-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
22,950,000,000 JPY
45,900,000,000 JPY
23,066,000,000 JPY
Ordinary profit (loss)
695,000,000 JPY
832,000,000 JPY
403,000,000 JPY
Profit (loss)
492,000,000 JPY
970,000,000 JPY
265,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
32,831,000,000 JPY
32,579,000,000 JPY
32,062,000,000 JPY
Total assets
72,920,000,000 JPY
70,188,000,000 JPY
70,937,000,000 JPY
Dividend paid per share
40.00
80.00
40.00
Basic earnings (loss) per share
29.31
56.16
109.61
8.28
29.81
Diluted earnings per share
Equity-to-asset ratio
0.450 xbrli:pure
0.464 xbrli:pure
0.452 xbrli:pure
Net cash provided by (used in) operating activities
2,280,000,000 JPY
1,420,000,000 JPY
815,000,000 JPY
Net cash provided by (used in) investing activities
-1,020,000,000 JPY
-984,000,000 JPY
-1,160,000,000 JPY
Net cash provided by (used in) financing activities
1,692,000,000 JPY
69,000,000 JPY
1,973,000,000 JPY
Cash and cash equivalents
8,409,000,000 JPY
5,457,000,000 JPY
6,579,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.